NasdaqCM - Nasdaq Real Time Price USD

Co-Diagnostics, Inc. (CODX)

Compare
1.2300 -0.0300 (-2.42%)
As of 12:13 PM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
9,136.9690
6,812.0380
34,218.2090
97,885.6030
74,552.7580
--
Cost of Revenue
3,670.2660
4,184.9490
5,481.0930
11,574.9440
16,591.3460
--
Gross Profit
5,466.7030
2,627.0890
28,737.1160
86,310.6590
57,961.4120
--
Operating Expense
44,167.1970
45,333.3230
40,328.4070
40,245.7070
16,267.7720
--
Operating Income
-38,700.4940
-42,706.2340
-11,591.2910
46,064.9520
41,693.6400
--
Net Non Operating Interest Income Expense
1,472.5700
1,161.9130
704.0450
45.6310
97.2150
--
Other Income Expense
1,421.7080
3,433.7650
-7,959.9880
-474.7880
778.2100
--
Pretax Income
-35,806.2160
-38,110.5560
-18,847.2340
45,635.7950
42,569.0650
--
Tax Provision
1,763.7940
-2,777.6910
-4,608.9850
8,977.2310
90.5360
--
Net Income Common Stockholders
-37,570.0100
-35,332.8650
-14,238.2490
36,658.5640
42,478.5290
--
Diluted NI Available to Com Stockholders
-37,570.0100
-35,332.8650
-14,238.2490
36,658.5640
42,478.5290
--
Basic EPS
-1.26
-1.20
-0.45
1.27
1.59
--
Diluted EPS
-1.26
-1.20
-0.45
1.23
1.52
--
Basic Average Shares
29,696.4040
29,346.5990
31,479.0280
28,874.5550
26,720.1330
--
Diluted Average Shares
29,696.4040
29,346.5990
31,479.0280
29,903.6860
28,000.3410
--
Total Operating Income as Reported
-38,700.4940
-42,706.2340
-26,979.8370
46,064.9520
41,693.6400
--
Total Expenses
47,837.4630
49,518.2720
45,809.5000
51,820.6510
32,859.1180
--
Net Income from Continuing & Discontinued Operation
-37,570.0100
-35,332.8650
-14,238.2490
36,658.5640
42,478.5290
--
Normalized Income
-38,848.6977
-38,422.6135
-8,479.8497
36,694.1811
42,478.7036
--
Interest Income
1,472.5700
1,161.9130
704.0450
45.6310
97.2150
--
Interest Expense
--
--
--
--
--
106.4370
Net Interest Income
1,472.5700
1,161.9130
704.0450
45.6310
97.2150
--
EBIT
-38,700.4940
-42,706.2340
-11,591.2910
46,064.9520
41,693.6400
--
EBITDA
-37,422.3680
-41,475.7600
-10,308.5730
46,400.3150
41,832.2750
--
Reconciled Cost of Revenue
3,670.2660
4,184.9490
5,481.0930
11,574.9440
16,591.3460
--
Reconciled Depreciation
1,278.1260
1,230.4740
1,282.7180
335.3630
138.6350
--
Net Income from Continuing Operation Net Minority Interest
-37,570.0100
-35,332.8650
-14,238.2490
36,658.5640
42,478.5290
--
Total Unusual Items Excluding Goodwill
1,618.5920
3,333.0620
-7,627.0190
-44.3550
-0.1750
--
Total Unusual Items
1,618.5920
3,333.0620
-7,627.0190
-44.3550
-0.1750
--
Normalized EBITDA
-39,040.9600
-44,808.8220
-2,681.5540
46,444.6700
41,832.4500
--
Tax Rate for Calcs
0.0002
0.0001
0.0002
0.0002
0.0000
--
Tax Effect of Unusual Items
339.9043
243.3135
-1,868.6197
-8.7379
-0.0004
--
12/31/2019 - 7/12/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers